Literature DB >> 21184186

Measuring health-related quality of life in Kashin-Beck disease using EQ-5D.

Umer Farooq1, Xiong Guo, Ling-Hsiang Chuang, Hua Fang, Guihua Zhuang, Chuantao Xia.   

Abstract

PURPOSE: To assess health-related quality of life in patients with Kashin-Beck disease (KBD) in China.
METHODS: A total of 684 participants from endemic areas of the Shaanxi province in China were recruited through a multistage stratified random sampling. Amongst those, 368 participants were diagnosed with KBD while the rest of 316 were non-KBD participants. Differences between KBD and non-KBD groups were analysed for the percentage of reporting any problems in each of EQ-5D five dimensions, EQ-5D index scores and visual analogue scale (VAS) scores.
RESULTS: KBD patients have a higher percentage of reporting any problems in each of EQ-5D dimension than non-KBD participants and a general population in Beijing. The most affected dimension is pain/discomfort, followed by mobility, anxiety/depression, and usual activities, and self-care being the last. The mean EQ-5D index and VAS scores for KBD patients are significantly lower than those of non-KBD participants.
CONCLUSION: This study is the first attempt to measure the health-related quality of life in KBD patients. The results of the study show that KBD has a severe impact on patients' health-related quality of life as measured by EQ-5D. It particularly causes great problems in the dimensions of pain/discomfort, mobility and anxiety/depression.

Entities:  

Mesh:

Year:  2010        PMID: 21184186     DOI: 10.1007/s11136-010-9820-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  17 in total

1.  Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore.

Authors:  N Luo; L H Chew; K Y Fong; D R Koh; S C Ng; K H Yoon; S Vasoo; S C Li; J Thumboo
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

2.  Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China.

Authors:  Hong Wang; David A Kindig; John Mullahy
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

3.  Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).

Authors:  N P Hurst; P Kind; D Ruta; M Hunter; A Stubbings
Journal:  Br J Rheumatol       Date:  1997-05

4.  Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life.

Authors:  G I Kempen; J Ormel; E I Brilman; J Relyveld
Journal:  Am J Public Health       Date:  1997-01       Impact factor: 9.308

5.  Modeling valuations for EuroQol health states.

Authors:  P Dolan
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

6.  Responsiveness of generic and specific measures of health outcome in low back pain.

Authors:  A M Garratt; J Klaber Moffett; A J Farrin
Journal:  Spine (Phila Pa 1976)       Date:  2001-01-01       Impact factor: 3.468

7.  Which chronic conditions are associated with better or poorer quality of life?

Authors:  M A Sprangers; E B de Regt; F Andries; H M van Agt; R V Bijl; J B de Boer; M Foets; N Hoeymans; A E Jacobs; G I Kempen; H S Miedema; M A Tijhuis; H C de Haes
Journal:  J Clin Epidemiol       Date:  2000-09       Impact factor: 6.437

8.  Reliability and validity of the EuroQol in patients with osteoarthritis of the knee.

Authors:  M Fransen; J Edmonds
Journal:  Rheumatology (Oxford)       Date:  1999-09       Impact factor: 7.580

9.  Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study.

Authors:  H S J Picavet; N Hoeymans
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

10.  Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status.

Authors:  R Moreno-Reyes; C Suetens; F Mathieu; F Begaux; D Zhu; M T Rivera; M Boelaert; J Nève; N Perlmutter; J Vanderpas
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

View more
  6 in total

1.  Association of clinical features of bone and joint lesions between children and parents with Kashin-Beck disease in Northwest China.

Authors:  Chun-Xia Cao; Yin-Gang Zhang; Shi-Xun Wu; Mohammad Imran Younas; Xiong Guo
Journal:  Clin Rheumatol       Date:  2013-04-28       Impact factor: 2.980

2.  Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.

Authors:  Hua Fang; Umer Farooq; Dimiao Wang; Fangfang Yu; Mohammad Imran Younus; Xiong Guo
Journal:  Springerplus       Date:  2016-11-07

Review 3.  The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.

Authors:  Ting Zhou; Haijing Guan; Jiaqi Yao; Xiaomo Xiong; Aixia Ma
Journal:  Qual Life Res       Date:  2018-07-06       Impact factor: 4.147

4.  Altered Expression of the Hedgehog Pathway Proteins BMP2, BMP4, SHH, and IHH Involved in Knee Cartilage Damage of Patients With Osteoarthritis and Kashin-Beck Disease.

Authors:  Huan Deng; Xiang Xiao; Mumba Mulutula Chilufya; Lichun Qiao; Yizhen Lv; Ziwei Guo; Jian Lei; Jiaxin Liu; Yan Zhao; Jiaheng Zhang; Wenyue Wang; Jing Han; Chengjuan Qu
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

5.  Health-related quality of life in different trimesters during pregnancy.

Authors:  Huailiang Wu; Weiwei Sun; Hanqing Chen; Yanxin Wu; Wenjing Ding; Shangqiang Liang; Xinyu Huang; Haitian Chen; Qing Zeng; Zhuyu Li; Peng Xiong; Jian Huang; Babatunde Akinwunmi; Casper J P Zhang; Wai-Kit Ming
Journal:  Health Qual Life Outcomes       Date:  2021-07-21       Impact factor: 3.186

6.  Are social security policies for Chinese landless farmers really effective on health in the process of Chinese rapid urbanization? A study on the effect of social security policies for Chinese landless farmers on their health-related quality of life.

Authors:  Ying Liang; Wanyi Lu; Wei Wu
Journal:  Int J Equity Health       Date:  2014-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.